Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers
Cottu, Paul H, Bonneterre, Jacques, Varga, Andrea, Campone, Mario, Leary, Alexandra, Floquet, Anne, Berton-Rigaud, Dominique, Sablin, Marie-Paule, Lesoin, Anne, Rezai, Keyvan, Lokiec, François M, Lhomme, Catherine, Bosq, Jacques, Bexon, Alice S, Gilles, Erard M, Proniuk, Stefan, Dieras, Veronique, Jackson, David M, Zukiwski, Alexander, Italiano, Antoine
Published in PloS one (10.10.2018)
Published in PloS one (10.10.2018)
Get full text
Journal Article
Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus
Bonneterre, Jacques, Hutt, Emilie, Bosq, Jacques, Graham, J. Dinny, Powell, Matthew A, Leblanc, Eric, Fujiwara, Keiichi, Herzog, Thomas J, Coleman, Robert L, Clarke, Christine L, Gilles, Erard M, Zukiwski, Alexander A, Monk, Bradley J
Published in Gynecologic oncology (01.09.2015)
Published in Gynecologic oncology (01.09.2015)
Get full text
Journal Article
Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort
Bonneterre, Jacques, Bosq, Jacques, Jamme, Philippe, Valent, Alexander, Gilles, Erard M, Zukiwski, Alexander A, Fuqua, Suzanne A W, Lange, Carol A, O'Shaughnessy, Joyce
Published in ESMO open (2016)
Published in ESMO open (2016)
Get full text
Journal Article
Clinical and pathologic correlation of the activated form of the androgen receptor (AR) in breast cancer (BC)
Jamme, Philippe, Bosq, Jacques, Gilles, Erard M., Zukiwski, Alexander, Alleaume, Charline, Gilles, Ambroise, Bonneterre, Jacques
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Clinical and pathologic correlation of the activated form of the estrogen receptor beta (ERβ) in breast cancer (BC)
Hutt, Emilie, Bosq, Jacques, Gilles, Erard M., Zukiwski, Alexander, Alleaume, Charline, Gilles, Barthelemy Octavius, Bonneterre, Jacques
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Abstract 1646: Synthesis of [11C]onapristone for clinical investigation
Madar, Olivier, Fouque, Julien, Proniuk, Stefan, Rezai, Keyvan, Huguet, Samuel, Zukiwski, Alexander, Gilles, Erard M., Bexon, Alice S., Lokiec, François
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article
Validation of a population pharmacokinetic (PPK) model for onapristone (ONA) in patients (pts) with cancer: Analysis of 2 clinical trials
Rezai, Keyvan, Huguet, Samuel, Bret, Fanny, Cottu, Paul H., Attard, Gerhardt, Italiano, Antoine, Varga, Andrea, Bonneterre, Jacques, Campone, Mario, Jayaram, Anuradha, Bexon, Alice Susannah, Gilles, Erard M., Proniuk, Stefan, Barranco, Charles, Zukiwski, Alexander, Lokiec, Francois Marc
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Clinical and pathologic correlation of the activated form of the estrogen receptor (ER) in breast cancer (BC)
Bonneterre, Jacques, Gilles, Erard M., Zukiwski, Alexander A., Bosq, Jacques, Valent, Alexander, Hutt, Emilie, Fuqua, Suzanne A.W.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Identification of the activated form of the estrogen receptor (ER) in breast cancer (BC)
Gilles, Erard M., Bosq, Jacques, Fuqua, Suzanne A.W., Zukiwski, Alexander A., Caillaud, Jean-Michel, Gilles, Barthelemy, Bonneterre, Jacques
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Safety and pharmacokinetic (PK) results from phase 1 of an ongoing phase 1-2 study of onapristone (ONA) in patients (pts) with progesterone receptor (PR)-expressing cancers
Italiano, Antoine, Bonneterre, Jacques, Varga, Andrea, Rezai, Keyvan, Campone, Mario, Floquet, Anne, Leary, Alexandra, Berton-Rigaud, Dominique, Sablin, Marie-Paule, Lesoin, Anne, Lokiec, Francois Marc, Lhommé, Catherine, Bexon, Alice Susannah, Gilles, Erard M., Bisaha, Joseph, Zukiwski, Alexander, Cottu, Paul H.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Onapristone (ONA) in progesterone receptor (PR)-expressing tumors: Efficacy and biomarker results of a dose-escalation phase 1 study
Cottu, Paul H., Italiano, Antoine, Varga, Andrea, Campone, Mario, Leary, Alexandra, Floquet, Anne, Berton-Rigaud, Dominique, Sablin, Marie-Paule, Lesoin, Anne, Lhomme, Catherine, Bexon, Alice Susannah, Gilles, Erard M., Jackson, David, Bisaha, Joseph, Zukiwski, Alexander, Bosq, Jacques, Bonneterre, Jacques
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Independent characterization by duel staining of progesterone receptor (PR) and estrogen receptor (ER) in breast cancer (BC)
Zukiwski, Alexander A., Caillaud, Jean-Michel, Bosq, Jacques, Fuqua, Suzanne A. W., Lange, Carol A., O'Shaughnessy, Joyce, Gilles, Erard M., Bonneterre, Jacques
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Identification of the activated form of the progesterone receptor (PR) in breast cancer (BC)
Bosq, Jacques, Caillaud, Jean-Michel, Lange, Carol A., Fuqua, Suzanne A. W., O'Shaughnessy, Joyce, Gilles, Erard M., Zukiwski, Alexander A., Bonneterre, Jacques
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
A randomized, parallel-dose phase 1 study of onapristone (ONA) in patients (pts) with progesterone receptor (PR)-expressing cancers
Cottu, Paul H., Varga, Andrea, Giacchetti, Sylvie, Leblanc, Eric, Espie, Marc, Gazzah, Anas, Dieras, Veronique, Lhomme, Catherine, Lokiec, Francois Marc, Rezai, Keyvan, Bexon, Alice Susannah, Gilles, Erard M., Bisaha, Joseph, Zukiwski, Alexander, Bonneterre, Jacques
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Phase 2 clinical study of onapristone (ONA) in patients (pts) with uterine endometrioid adenocarcinoma (EC) expressing the activated progesterone receptor (APR pos )
Bonneterre, Jacques, Leary, Alexandra, Campone, Mario, Italiano, Antoine, Sablin, Marie-Paule, Floquet, Anne, Berton-Rigaud, Dominique, Lhommé, Catherine, Lesoin, Anne, Chocteau-Bouju, Dorothee, Fabbro, Michel, Favier, Laure, Gladieff, Laurence, Ray-Coquard, Isabelle, Bexon, Alice Susannah, Gilles, Erard M., Bisaha, Joseph, Zukiwski, Alexander, Cottu, Paul H.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Determination of the activated form of the progesterone receptor (PR) in endometrial cancer (EC)
Graham, Dinny, Bosq, Jacques, Caillaud, Jean-Michel, Powell, Matthew A., Leblanc, Eric, Fujiwara, Keiichi, Herzog, Thomas J., Monk, Bradley J., Clarke, Christine, Zukiwski, Alexander A., Gilles, Erard M., Coleman, Robert L.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article